Through collaboration with European health bodies, Global Health EDCTP3 aims to strengthen tuberculosis prevention and treatment, especially involving children and people with weakened immune systems
Phages that kill bacteria are seen as a possible solution to the waning power of antibiotics. But research funding is lacking and existing routes to approval and commercialisation are not suitable for these therapies, say UK MPs
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.